Drugs / budesonide/formoterol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01253473 | Apr 2012 → Sep 2015 | chronic obstructive pulmonary disease | National Jewish Health | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | budesonide/formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01253473 ↗ |
| Route | Inhaled | “Inhaled budesonide/formoterol (160/4.5 mcg Symbicort®)” NCT01253473 ↗ |